BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 31311722)

  • 1. Stability of Intracavitary Applicator Placement for HDR Brachytherapy of Cervix Cancer.
    Balsdon A; Timotin E; Hunter R; Diamond K
    J Med Imaging Radiat Sci; 2019 Sep; 50(3):441-448. PubMed ID: 31311722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.
    Shi D; He MY; Zhao ZP; Wu N; Zhao HF; Xu ZJ; Cheng GH
    Asian Pac J Cancer Prev; 2015; 16(9):3945-9. PubMed ID: 25987066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
    Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
    Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method to assess the need for re-planning HDR brachytherapy tandem and ring treatments.
    Gray T; Cherian S; Amarnath S; Guo B; Xia P; Wilkinson A
    Med Dosim; 2024 Apr; ():. PubMed ID: 38616141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
    Beriwal S; Kim H; Heron DE; Selvaraj R
    Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
    Davidson MT; Yuen J; D'Souza DP; Batchelar DL
    Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
    Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
    Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
    Meerschaert R; Nalichowski A; Burmeister J; Paul A; Miller S; Hu Z; Zhuang L
    J Appl Clin Med Phys; 2016 Nov; 17(6):323-333. PubMed ID: 27929505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3T multiparametric MRI-guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator.
    Fredman E; Traughber B; Podder T; Colussi V; Zheng Y; Russo S; Herrmann K; Paspulati R; Waggoner S; Zanotti K; Nagel C; Nakayama J; Machtay M; Ellis R
    Brachytherapy; 2018; 17(2):334-344. PubMed ID: 29097137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric impact of applicator displacement on three-dimensional image-guided high-dose-rate brachytherapy treatments for cervical cancer.
    Jayarathna S; Hoang M; Badkul R; Hoover A
    J Contemp Brachytherapy; 2023 Oct; 15(5):334-343. PubMed ID: 38026073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT and MR image fusion of tandem and ring applicator using rigid registration in intracavitary brachytherapy planning.
    Oinam AS; Tomar P; Patel FD; Singh L; Rai B; Bahl A
    J Appl Clin Med Phys; 2014 Mar; 15(2):4206. PubMed ID: 24710430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional rectal and sigmoid mucosal points and doses in high dose rate intracavitary brachytherapy for carcinoma cervix: a dosimetric study.
    Mahantshetty U; Tiwana MS; Jamema S; Mishra S; Engineer R; Deshpande D; Shrivastava S
    J Cancer Res Ther; 2011; 7(3):298-303. PubMed ID: 22044811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
    Jacob D; Lamberto M; DeSouza Lawrence L; Mourtada F
    Brachytherapy; 2017; 16(3):624-629. PubMed ID: 28365083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dosimetric comparison of Volumetric Modulated Arc Therapy (VMAT) and High Dose Rate (HDR) brachytherapy in localized cervical cancer radiotherapy.
    Wali L; Helal A; Darwesh R; Attar M
    J Xray Sci Technol; 2019; 27(3):473-483. PubMed ID: 30958322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
    Hopfensperger KM; Adams QE; Kim Y; Wu X; Xu W; Patwardhan K; Flynn RT
    Med Phys; 2023 Oct; 50(10):6469-6478. PubMed ID: 37643427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
    Sharma M; Fields EC; Todor DA
    Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.
    Yan J; Zhu J; Chen K; Yu L; Zhang F
    Radiat Oncol; 2021 Aug; 16(1):144. PubMed ID: 34348758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial reproducibility of the ring and tandem high-dose rate cervix applicator.
    Bahena JH; Martinez A; Yan D; Mele E; Edmunson G; Brown D; Hardy M; Brabbins D; Gustafson G
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):13-9. PubMed ID: 9588912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interfraction variations in doses at OARs during three-dimensional high dose rate brachytherapy planning of cervix cancer.
    Dhaka S; Rajani A; Kumar HS; Sharma N; Jakhar SL; Harsh K
    J Cancer Res Ther; 2023; 19(5):1136-1141. PubMed ID: 37787275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.